Deadline: 21-Apr-2026
The European Commission is offering €8–60 million in grants to fund research that integrates fragmented health innovation across disciplines and technologies. Projects should focus on people-centred healthcare solutions, harmonised data, innovative technologies, and green transitions, forming collaborative public-private consortia to address unmet public health needs.
Overview
The European Commission invites applications for grants to reduce fragmentation in health research and innovation. The goal is to accelerate technologically and socially innovative, patient-focused healthcare solutions while fostering the integration of medical and technological disciplines.
Key objectives include:
- Developing integrated healthcare solutions across medical and technological domains.
- Promoting safe, effective health technologies through harmonised data generation.
- Accelerating the adoption of innovative products, services, and tools in healthcare.
- Supporting industry innovation and green transitions in healthcare delivery and manufacturing.
- Funding pre-competitive research that improves prevention, diagnosis, treatment, and recovery processes.
Focus Areas
Integration of Fragmented Research
- Break down silos between medical disciplines and technological sectors.
- Foster cross-disciplinary collaboration for holistic healthcare solutions.
People-Centred Innovation
- Develop solutions that are patient-focused and socially innovative.
- Address unmet public health needs based on disease burden, economic impact, or innovation potential.
Data and Technology
- Use harmonised data to support innovation and regulatory compliance.
- Develop novel tools, platforms, technologies, and processes aligned with end-user requirements.
- Enable faster integration of products into healthcare pathways.
Industrial and Environmental Impact
- Support innovative manufacturing processes benefiting industry and patients.
- Promote the green transition in healthcare systems and industrial technologies.
Eligibility Criteria
- Open to all legal entities worldwide that meet Horizon Europe Regulation requirements.
- Applicants must form collaborative public-private consortia capable of integrating fragmented health research and innovation efforts.
- Proposals should demonstrate the ability to translate research into implementable solutions for healthcare or industrial applications.
Funding Details
- Project funding: €8,000,000 – €60,000,000 per project
- Funding model: Single-stage Horizon Joint Undertaking (JU) Research and Innovation Action
- Supports pre-competitive research for novel health solutions
How to Apply
- Form a consortium: Include public and private partners with complementary expertise.
- Identify unmet healthcare needs: Prioritise areas with high disease burden or innovation potential.
- Develop project proposal: Include objectives, methodology, expected impact, and integration plan.
- Conduct a landscape analysis: Avoid duplication and highlight potential synergies with existing initiatives.
- Submit the application according to Horizon Europe guidelines and deadlines.
Common Mistakes to Avoid
- Failing to clearly address fragmentation in health research.
- Proposing solutions without end-user focus or implementation plans.
- Overlooking existing initiatives, leading to duplication of efforts.
- Ignoring Horizon Europe eligibility and regulatory requirements.
- Not including cross-disciplinary or public-private collaboration.
FAQs
1. Who can apply for this grant?
Any legal entity worldwide that meets Horizon Europe Regulation requirements.
2. What types of projects are eligible?
Projects addressing fragmented health research, patient-centred solutions, innovative technologies, harmonised data, and green transitions.
3. What is the funding range?
€8,000,000 to €60,000,000 per project, supporting multiple initiatives.
4. What is the project duration?
Defined by the single-stage Horizon JU Research and Innovation Action guidelines.
5. Are international consortia allowed?
Yes, collaborative public-private consortia worldwide are encouraged.
6. Do proposals need to address real healthcare needs?
Yes, projects should demonstrate impact on disease burden, economic efficiency, or transformational innovation potential.
7. Is a landscape analysis required?
Yes, to avoid overlap with existing initiatives and identify potential synergies.
Why This Funding Matters
This initiative supports the creation of integrated, patient-focused healthcare solutions, strengthens cross-disciplinary collaboration, accelerates innovation adoption, and encourages sustainable industrial practices. By reducing fragmentation, the programme enhances efficiency, safety, and societal impact of healthcare technologies.
Conclusion
The European Commission’s integrated health innovation funding is a strategic opportunity for consortia to develop novel, cross-disciplinary solutions that benefit patients, industry, and the environment. Applicants who form strong collaborative partnerships and address unmet healthcare needs with actionable solutions can significantly impact Europe’s healthcare ecosystem.
For more information, visit European Commission.
